A drug manufacturer announced this week it is recalling lots of blood pressure medication Quinapril after a cancer-causing impurity was discovered, according to an announcement carried by the U.S. Food and Drug Administration (FDA).
Lupin Pharmaceuticals Inc. said that it is voluntarily recalling four lots of Quinapril tablets due to the presence of nitrosamine, which was observed in recent testing that found levels above the acceptable daily intake level set by regulators. The company noted that it stopped marketing Quinapril tablets in September 2022.
